Bausch Health Cos., Inc. (BHC)
7.25
-0.20
(-2.68%)
USD |
NYSE |
Jan 15, 10:15
Bausch Health Cos. EPS Diluted (Quarterly): 0.4767 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Oncolytics Biotech, Inc. | -0.1032 |
| Aurinia Pharmaceuticals, Inc. | 0.232 |
| Edesa Biotech, Inc. | -0.3157 |
| Lexaria Bioscience Corp. | -0.0746 |
| Xenon Pharmaceuticals, Inc. | -1.147 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | 181.00M |
| Revenue (Quarterly) | 2.681B |
| Total Expenses (Quarterly) | 2.502B |
| Enterprise Value | 23.38B |
| Gross Profit Margin (Quarterly) | 62.59% |
| Profit Margin (Quarterly) | 6.75% |
| Earnings Yield | 13.37% |
| Operating Earnings Yield | 76.34% |
| Normalized Earnings Yield | 12.72 |